IP Library Granted Patent US 8,829,184
Granted Patent B2
US 8,829,184 · App. 13/641,237 · Granted Sep 9, 2014

Intermediates useful for the synthesis of pyrrolobenzodiazepines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,829,184
App. No.
13/641,237
Granted
Sep 9, 2014
Kind
B2
Abstract

A compound of formula (I): which is substantially free of any of the corresponding compound of formula (IB): methods of making such compounds, and the further transformation of such compounds.

Claims (220)

1. A compound of formula I:

wherein:

R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (I), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers, where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R s is selected from CF 3 , (CF 2 ) 3 CF 3 , CH 3 and

and

R C is selected:

(i) —C(═O)—OR c1 , where R C1 is a saturated C 1-4 alkyl group;

(ii) —CH 2 —O—C(═O)R c2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 )where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 a saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene,

which is substantially free of any of the corresponding compound of formula IB:

2. A compound according to claim 1 , wherein R 7 and R 8 are independently OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, pyridyl and furanyl.

3. A compound according to claim 1 , wherein R A is unsubstituted C 1-4 saturated alkyl.

4. A compound according to claim 3 , wherein R A is methyl.

5. A compound according to claim 1 which is a dimer, where each X is O.

6. A compound according to claim 1 which is a dimer, where R″ is a C 3 , C 5 or C 7 saturated alkylene group.

7. A compound according to claim 1 , wherein R S is CF 3 .

8. A compound according to claim 1 , wherein R C1 is methyl.

9. A compound according to claim 1 , wherein —Si—(R Si1 )(R Si2 )(R Si3 ) is TBDMS.

10. A method of synthesising a compound of formula I:

as defined in claim 1 , from a compound of formula II:

comprising treating II with the appropriate anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-tBu-pyridine at a temperature of −35° C. or lower in a dry organic solvent under a inert atmosphere.

11. The method according to claim 10 , wherein the reaction is carried out at a temperature of −40° C. or lower.

12. A compound of formula III:

wherein:

R 7 and R 8 are independently selected from: OR A ,where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (III), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers, where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R c is selected from:

(i) —C(═O)—OR c1 , where R c1 is a saturated C 1-4 alkyl group;

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 , are independently selected from C 1-6 a saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group or together form a C 2-3 alkylene; and

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-ox -alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O )—OR O , where R O is a C 1-7 alkyl group;

(v)—OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

wherein at least one of the unsaturated bonds is conjugated to the double bond present between C2 and C3; which is substantially free of any of the corresponding compound of formula IIIB:

13. A method of synthesising a compound of formula III:

wherein:

R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (III), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH; R 9 is selected from H, methyl and methoxy;

R C is selected from:

(i) —C(═O)—OR C1 , where R C1 is a saturated C 1-4 alkyl group;

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where Si1 , R Si2 , R Si3 are independently selected from C 1-6 a saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene; and

R 2 is selected from:

(i) an optionall substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 where R N1 and R N2 are C 1-7 alkly groups;

(iv) —C(═O)—OR O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group;

from a compound of formula I:

wherein:

R S is selected from CF 3 , (CF 2 ) 3 CF 3 , CH 3 and

and

comprising one of the following:

(i) a Suzuki coupling between a compound of formula I and an appropriate aryl boron derivative;

(ii) a Heck coupling with an appropriate alkene, acrylamide or acrylate;

(iii) a Stille coupling with an appropriate organotin reagent;

(iv) a Sonagishira coupling with an appropriate alkyne; or

(v) a hydride transfer using a triethylsilane, wherein the compound of formula I is synthesised from a compound of formula II:

comprising treating II with the appropriate anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-tBu-pyridine at a temperature of −35° C. or lower in a dry organic solvent under a inert atmosphere.

14. A compound of formula IV:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (IV), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers, where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy -alkylene and N—C 1-4 alkyl piperazinyl;

and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 where R N1 and R N2 are C 1-7 alkly groups;

(iv) —C(═O)—OR O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R D is selected from:

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene,

which is substantially free of any of the corresponding compound of formula IVB:

15. A compound according to claim 14 , wherein —Si—(R Si1 )(R Si2 )(R Si3 ) is TBDMS.

16. A compound according to claim 14 , wherein R C2 is methyl.

17. A method of synthesising a compound of formula IV:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (IV), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers, where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R c is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-ox -alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O )—OR O , where R O is a C 1-7 alkyl group;

(v) —OR O ;

—Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R D is selected from:

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene, from a compound of formula III:

wherein:

R C is selected from:

(i) —C(═O)—OR C1 , where R C1 is a saturated C 1-4 alkyl group;

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where Si1 , R Si2 , R Si3 are independently selected from C 1-6 a saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene; and

by one of the following:

(i) if R C is —C(═O)—OR C1 , conversion of —C(═O)—OR C1 to —CH 2 —O—C(═O)R C2 or —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), followed by:

(ii) if R C is —CH 2 —O—C(═O)R C2 , reduction of the nitro group by zinc in acetic acid or if R C is —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), reduction of the nitro group using zinc in 5% formic acid in ethanol;

(iii) if R C is —C(—YR C3 )(—YR C4 ), reduction of the nitro group using Cd/Pb couple, sodium dithionite or tin II chloride, wherein the compound of formula III is synthesised from a compound of formula II:

comprising treating II with the appropriate anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-tBu-pyridine at a temperature of −35° C. or lower in a dry organic solvent under a inert atmosphere.

18. A compound of formula V:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (V), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers, where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-ox -alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O )—OR O , where R O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R D is selected from:

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene; and

R 10 is a carbamate-based nitrogen protecting group, which is palladium-labile and/or labile under the conditions used to add the group:

or contains a moiety which is palladium-labile and/or is labile under the conditions used to add the group:

which is substantially free of any of the corresponding compound of formula VB:

19. A compound according to claim 18 , wherein R 10 is selected from one of:

where the asterisk indicates the point of attachment to the N10 position.

20. A compound according to claim 18 , wherein R 10 is of the formula:

where the asterisk indicates the point of attachment to the N10 position, G 1 is a functional group to form a connection to a cell binding agent, L 1 is a cleavable linker, L 2 is a covalent bond or together with —OC(═O)— forms a self-immolative linker.

21. A method of synthesising a compound of formula V:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (V), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O)—OR O , where R O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R D is selected from:

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene; and

R 10 is a carbamate-based nitrogen protecting group, which is palladium-labile and/or labile under the conditions used to add the group:

or contains a moiety which is palladium-labile and/or is labile under the conditions used to add the group:

from a compound of formula IV:

by reaction of IV with triphosgene to obtain the isocyanate followed by reaction with R 10 —OH, wherein the compound of formula IV is synthesised from a compound of formula II:

including the method comprising treating II with the appropriate anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-tBu-pyridine at a temperature of −35° C. or lower in a dry organic solvent under a inert atmosphere.

22. A compound of formula VI:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (VI), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers where R″ is a C 3-12 saturated alk lene rou which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O)—OR O , where R O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R 10 is a carbamate-based nitrogen protecting group, which is palladium-labile and/or labile under the conditions used to add the group:

or contains a moiety which is palladium-labile and/or is labile under the conditions used to add the group:

which is substantially free of any of the corresponding compound of formula VIB:

23. A method of synthesising a compound of formula VI:

wherein R 7 and R 8 are independently selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(═O)Me;

or R 7 and R 8 together form a group —O—(CH 2 ) m —O—, where m is 1 or 2;

or the compound is a dimer with each monomer independently being of formula (VI), where the R 7 groups or R 8 groups of each monomer form together a dimer bridge having the formula —X—R″—X— linking the monomers where R″ is a C 3-12 saturated alkylene group, which group may be interrupted by O, S, NH, NMe, phenylene or pyridylene, where the phenylene and pyridylene groups are optionally substituted by NH 2 , and each X is independently selected from O, S, or NH;

R 9 is selected from H, methyl and methoxy;

R 2 is selected from:

(i) an optionally substituted C 5-20 aryl group wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl; and

(ii) an optionally substituted C 2-5 alkenyl group or C 2-5 alkynyl group, wherein the optional substituents are chosen from:

(i) optionally substituted C 5-20 aryl groups wherein the optional substituents are chosen from halo, C 1-7 alkoxy, di-C 1-4 alkylamino-C 1-7 alkoxy, C 1-7 alkyl, bis-oxy-alkylene and N—C 1-4 alkyl piperazinyl;

(ii) —CN;

(iii) —C(═O)—NR N1 R N2 , where R N1 and R N2 are C 1-7 alkyl groups;

(iv) —C(═O)—OR O , where R O is a C 1-7 alkyl group;

(v) —OR O ;

(vi) —Sn(R SN ) 3 where R SN is a C 1-7 alkyl group; and

R 10 is a carbamate-based nitrogen protecting group, which is palladium-labile and/or labile under the conditions used to add the group:

or contains a moiety which is palladium-labile and/or is labile under the conditions used to add the group:

from a compound of formula V:

wherein R D is selected from:

(ii) —CH 2 —O—C(═O)R C2 , where R C2 is methyl or phenyl;

(iii) —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 saturated alkyl group and a phenyl group; and

(iv) —C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alkylene by one of the following:

(a) (i) where R D is —CH 2 —O—C(═O)Me, removal of the acetate protecting group, with potassium carbonate in aqueous methanol, or with lithium triethylborohydride;

(ii) where R D is —CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), removal of the silyl ether protecting group using: TBAF in THF; acetic acid in aqueous THF; CsF in DMF; or HF in pyridine; and

(b) oxidation of the product of step (a); or

(c) where R D is —C(—YR C3 )(—YR C4 ), removal of the acetal or thioacetal protecting groups, respectively with acid or reaction with Hg (II) salts, wherein the compound of formula V is synthesised from a compound of formula II:

including the method comprising treating II with the appropriate anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-tBu-pyridine at a temperature of −35° C. or lower in a dry organic solvent under a inert atmosphere.

24. A method according to claim 23 , wherein the oxidation is carried out with Dess-Martin periodinane.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE POSTAL CODE OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036932 FRAME: 0278. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Apr 11, 2017
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 042242/0389 →
CONFIRMATORY ASSIGNMENT Recorded Oct 23, 2015
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 036932/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: HOWARD, PHILIP WILSON; MASTERSON, LUKE; TIBERGHIEN, ARNAUD
To: SPIROGEN LIMITED
Reel/Frame 029371/0221 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: SPIROGEN LIMITED
To: SPIROGEN DEVELOPMENTS SARL
Reel/Frame 029371/0292 →